deltatrials
Completed NA INTERVENTIONAL 1-arm NCT02053168

A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair

A Prospective, Multicenter All Comers Study of a Novel Resorbable Mesh (Phasix Mesh) for Ventral or Incisional Hernia Repair

Sponsor: C. R. Bard

Conditions Incisional Hernia Ventral Hernia
Interventions Resorbable Mesh
Updated 6 times since 2017 Last updated: Apr 10, 2018 Started: Feb 28, 2014 Primary completion: Feb 23, 2017 Completion: Feb 23, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Incisional Hernia and Ventral Hernia, this trial is completed. The trial is conducted by C. R. Bard and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotActive Not Recruiting~May 2017 – ~Jun 2018 · 13 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. May 2017 — Jun 2018 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed · Phase: PHASE1_PHASE2 → NA

▶ Show 1 earlier version

  1. Jan 2017 — May 2017 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • C. R. Bard
Data source: C. R. Bard

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations